PeptideDB

Protocatechualdehyde 139-85-5

Protocatechualdehyde 139-85-5

CAS No.: 139-85-5

Protocatechualdehyde (Catechaldehyde) is a naturally occurring polyphenol compound extracted from Salvia miltiorrhiza. I
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Protocatechualdehyde (Catechaldehyde) is a naturally occurring polyphenol compound extracted from Salvia miltiorrhiza. It has a variety of bioactivities and can be extensively used in many medical fields as an antioxidant, anti-aging, antibacterial and anti~inflammatory agent.

Physicochemical Properties


Molecular Formula C7H6O3
Molecular Weight 138.1207
Exact Mass 138.031
CAS # 139-85-5
PubChem CID 8768
Appearance Light yellow to brown solid powder
Density 1.4±0.1 g/cm3
Boiling Point 295.4±20.0 °C at 760 mmHg
Melting Point 150-157 °C(lit.)
Flash Point 146.7±18.3 °C
Vapour Pressure 0.0±0.6 mmHg at 25°C
Index of Refraction 1.674
LogP 1.14
Hydrogen Bond Donor Count 2
Hydrogen Bond Acceptor Count 3
Rotatable Bond Count 1
Heavy Atom Count 10
Complexity 124
Defined Atom Stereocenter Count 0
InChi Key IBGBGRVKPALMCQ-UHFFFAOYSA-N
InChi Code

InChI=1S/C7H6O3/c8-4-5-1-2-6(9)7(10)3-5/h1-4,9-10H
Chemical Name

3,4-dihydroxybenzaldehyde
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro Protonacladehyde (PCA) treatment of MCF-7 cells at 50, 100 μM for 24 and 48 hours significantly decreased cell proliferation by 11% and 20% in the 24 hour period and by 22% and 27% in the 48 hour period, respectively. [2]. MCF-7 cells treated with 50 μM and 100 μM of protocatechuic aldehyde for 24 hours showed a 1.9- and 2.6-fold increase, respectively. PCA suppresses the enzymatic activity of HDAC and inhibits estrogen receptor (ER) active (MCF-7) mammary gland protocatechualdehyde (0, 100, and 200 μM, in HCT116 and SW480 cells, for 48 hours).
The minimum inhibitory concentration (MIC) of Protocatechualdehyde (PCA) against Ralstonia solanacearum was 20 µg/mL, and the minimum bactericidal concentration (MBC) was 40 µg/mL[1].
In growth curve assays, PCA at concentrations of 30 and 40 µg/mL significantly inhibited the growth of R. solanacearum, with 40 µg/mL nearly completely stopping growth after 26 hours of incubation[1].
Scanning electron microscopy (SEM) revealed that PCA treatment (30 and 40 µg/mL) damaged the surface structure and cellular integrity of R. solanacearum cells, causing them to become longer and narrower compared to untreated cells[1].
PCA inhibited biofilm formation by R. solanacearum in a concentration-dependent manner; treatment with 30 µg/mL and 40 µg/mL PCA significantly reduced biofilm formation by 38.56%/37.27% and 48.11%/38.90% at 24 and 36 hours, respectively, compared to the control[1].
PCA significantly inhibited the swarming motility of R. solanacearum in a dose-dependent manner at concentrations ranging from 10 to 40 µg/mL[1].
ln Vivo In a greenhouse pot experiment, soil drench application of Protocatechualdehyde (PCA) at 40 µg/mL effectively reduced the incidence of bacterial wilt on tobacco plants inoculated with R. solanacearum[1].
The control efficacy of PCA treatment reached 92.01% at nine days post-inoculation, which was significantly higher than the 47.31% efficacy achieved by streptomycin (40 µg/mL) treatment at the same time point[1].
The disease index for PCA-treated plants was 18.06 and 48.82 at 15 and 19 days post-inoculation, respectively, significantly lower than the control group (68.06 and 97.22) and comparable to or better than the streptomycin treatment group (51.22 and 78.65)[1].
Cell Assay Cell proliferation assay [2]
Cell Types: Human breast cancer cells (MCF-7 and MDA-MB-231)
Tested Concentrations: 0, 5, 10, 25, PCA treatment was observed to inhibit HDAC activity in a dose-dependent manner [3]. , 50 and 100 μM
Incubation Duration: 24, 48 hrs (hours)
Experimental Results: Inhibition of MCF-7 cell growth.

Apoptosis analysis [2]
Cell Types: Human breast cancer cells (MCF-7 and MDA-MB-231)
Tested Concentrations: 0, 5, 10, 25, 50 and 100 μM
Incubation Duration: 24, 48 hrs (hours)
Experimental Results: Apoptosis Increased apoptosis of MCF-7 cells.
MIC/MBC Determination: The MIC and MBC of PCA against R. solanacearum were determined using the agar dilution method[1]. Bacterial suspensions were spread onto agar plates containing serial dilutions of PCA (10, 20, 30, 40 µg/mL)[1]. Plates were incubated at 30°C, and the MIC (no visible growth after 48 h) and MBC (no visible growth after 96 h) were recorded[1].
Antimicrobial Assay (Growth Curve): The antibacterial activity was evaluated by monitoring growth curves in liquid culture[1]. PCA was added to broth at final concentrations of 10, 20, 30, or 40 µg/mL, inoculated with R. solanacearum, and incubated with shaking at 30°C[1]. Optical density at 600 nm was measured at 2-hour intervals for 36 hours[1].
Bacterial Morphology (SEM): R. solanacearum cells in logarithmic phase were treated with PCA (30 or 40 µg/mL) for 12 hours with shaking[1]. Cells were collected, washed, fixed with glutaraldehyde, dehydrated through a graded ethanol series, and finally suspended in tert-butanol before being mounted and gold-coated for SEM observation[1].
Biofilm Formation Assay: Biofilm formation was quantified using a crystal violet staining method in 96-well plates[1]. R. solanacearum cultures containing different concentrations of PCA were added to wells and incubated statically at 30°C for 12, 24, or 36 hours[1]. After washing, biofilms were stained with crystal violet, dissolved in ethanol, and the absorbance was measured at 490 nm[1].
Swarming Motility Assay: Swarming motility was assessed on semisolid agar (0.35%) plates containing different concentrations of PCA[1]. Bacterial suspensions were spot-inoculated at the center of the plates[1]. The diameter of the migration zone was measured in two perpendicular directions after incubation at 28°C for 24 and 48 hours[1].
Animal Protocol Greenhouse Efficacy Trial: Tobacco plants were inoculated by applying 5 mL of a R. solanacearum suspension to the rhizosphere[1]. Two days later, plants were treated by irrigating the roots with 10 mL of a PCA solution (40 µg/mL) or a streptomycin solution (40 µg/mL, positive control)[1]. Control plants received a water and solvent mixture[1]. Plants were grown in a greenhouse at 30°C and 85-90% relative humidity[1]. Disease incidence was assessed every two days from 7 to 19 days post-inoculation using a 0-4 disease rating scale[1].
Toxicity/Toxicokinetics The solvent dimethyl sulfoxide (DMSO) used to dissolve PCA had no effect on the growth of R. solanacearum at the tested concentrations in control experiments[1].
No phytotoxicity or adverse effects on tobacco plants were reported from the greenhouse experiment following root irrigation with the PCA solution[1]. The study mentions that botanical compounds like PCA generally have advantages such as being easily decomposed, not significantly toxic to vertebrates and host plants, and causing less environmental pollution[1].
References

[1]. Evaluation of the Antibacterial Effects and Mechanism of Action of Protocatechualdehyde against Ralstonia solanacearum. Molecules. 2016 Jun 9;21(6).

[2]. Anticancer activity of protocatechualdehyde in human breast cancer cells. J Med Food. 2014 Aug;17(8):842-8.

[3]. Protocatechualdehyde possesses anti-cancer activity through downregulating cyclin D1 and HDAC2 in human colorectal cancer cells. Biochem Biophys Res Commun. 2013 Jan 4;430(1):381-6.

Additional Infomation 3,4-dihydroxybenzaldehyde is a dihydroxybenzaldehyde.
Also known as protocatechuic aldehyde, protocatechualdehyde is a naturally-occuring phenolic aldehyde that is found in barley, green cavendish bananas, grapevine leaves and root of the herb S. miltiorrhiza. Protocatechualdehyde possesses antiproliferative and pro-apoptotic properties against human breast cancer cells and colorectal cancer cells by reducing the expression of pro-oncogenes β-catenin and cyclin D1.
3,4-Dihydroxybenzaldehyde has been reported in Salvia miltiorrhiza, Hymenochaete xerantica, and other organisms with data available.
See also: Black Cohosh (part of).
Protocatechualdehyde (PCA) is a natural polyphenolic compound (phenolic aldehyde) isolated from the roots of Salvia miltiorrhiza[1].
The study suggests that the antibacterial mechanism of PCA against R. solanacearum involves damaging the bacterial cell structure and inhibiting biofilm formation and swarming motility[1].
This is reported as the first study concerning the antibacterial effects of PCA on plant-pathogenic bacteria[1].
PCA is proposed as a potential environmentally friendly antibacterial agent for controlling bacterial wilt caused by R. solanacearum[1].

Solubility Data


Solubility (In Vitro) DMSO : ≥ 50 mg/mL (~362.00 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (18.10 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (18.10 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 2.5 mg/mL (18.10 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 7.2401 mL 36.2004 mL 72.4008 mL
5 mM 1.4480 mL 7.2401 mL 14.4802 mL
10 mM 0.7240 mL 3.6200 mL 7.2401 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.